Friday, March 14, 2025 | 05:09 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

PE-VC investments in pharma grow 38% in H1

The year saw some major deals, with firms like Intas Pharma raising $106 mn in April

chart
Premium

Sohini Das Ahmedabad
The first half of 2017 has seen a 38 per cent jump in private equity and venture capital (PE-VC) investments in the pharmaceutical sector, compared to the year-ago period. 

The year has seen some major deals in this sector, with players like Intas Pharmaceuticals raising $106 million from Capital International in April. 

In all, seven deals involving an investment of $177 million took place during this period, compared to five deals in H12016 with a value of $128 million. As the PE-VC interest in the pharma space heats up, secondary deals are taking place. Capital International picked up ChrysCapital LLC’s

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in